In a Breztri commercial that launched a year ago, a man using the AstraZeneca COPD inhaler was able to participate in hiking and other outdoor activities via an RV road trip. In this year’s spot, a ...
MyChesCo on MSN
AstraZeneca reports phase III results for BREZTRI in asthma
WILMINGTON, DE — AstraZeneca (NYSE: AZN) said full results from the Phase III KALOS and LOGOS trials, published in The Lancet ...
On Friday, AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca ...
Full results from the positive Phase III KALOS and LOGOS trials published in The Lancet Respiratory Medicine showed AstraZeneca’s BREZTRI Aerosphere (budesonide ...
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRIin patients with uncontrolled asthma published in The Lancet Respiratory Medicine Full results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results